Lead Nanoparticle Contrast Agents in Alginate Gels for Vascular Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current X-ray contrast agents for vascular imaging, such as barium sulfate and bismuth-containing nanoparticles, tend to clog at the capillary level, preventing them from entering the venous system and potentially causing damage, highlighting a need for stable and effective contrast agents that can accurately image vasculature without causing harm.
Innovation Solution
Development of injectable contrast agents comprising nanoparticles with cores made of abellaite, hydrocerussite, lead (II) carbonate, lead (II) tungstate, or bismuth oxide, capped with oligomers or polymers and dispersed in an alginate gel precursor solution, allowing for stable dispersion and imaging of vasculature using X-ray techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If barium sulfate particles are used as contrast agents, then radiodensity is improved, but particle size causes capillary clogging and vascular damage
Solution Approach 1:
The patent segments the contrast agent into two functional components: radiopaque nanoparticles (providing X-ray contrast) and biocompatible polymer carriers (enabling safe circulation). This segmentation allows the radiopaque material to be delivered in a form that does not clog capillaries, resolving the contradiction between achieving sufficient radiodensity and avoiding vascular damage from large particle sizes
Solution Approach 2:
The patent creates composite materials by combining radiopaque nanoparticle cores with biocompatible polymer shells or matrices. This composite structure integrates the high radiodensity of heavy metal-based nanoparticles with the safety and biocompatibility of polymer materials, enabling both effective imaging and safe circulation through the vascular system
2Reliability
If larger contrast agent particles are used to improve radiopacity, then imaging quality is improved, but capillary permeability deteriorates
Solution Approach 1:
The patent segments the contrast agent functionality between small radiopaque nanoparticles (providing radiopacity) and polymer carriers (enabling circulation). The segmented design allows the active radiopaque component to be delivered at effective concentrations while the carrier system maintains appropriate size for vascular penetration
Solution Approach 2:
The patent changes the size parameter of the contrast agent delivery system by using polymer-encapsulated nanoparticles rather than bare large particles. This parameter change enables the contrast agent to pass through capillaries while maintaining sufficient radiopacity through the concentrated nanoparticle core
3Ease of manufacture
If unstable contrast agents are used, then manufacturing simplicity is improved, but imaging accuracy deteriorates due to dissociation
Solution Approach 1:
The patent creates composite materials by combining radiopaque nanoparticle cores with biocompatible polymer shells or matrices. This composite structure integrates the high radiodensity of heavy metal-based nanoparticles with the safety and biocompatibility of polymer materials, enabling both effective imaging and safe circulation through the vascular system
Solution Approach 2:
The patent introduces polymer carriers as intermediary substances that stabilize the radiopaque nanoparticles. The polymer acts as a protective intermediary that prevents nanoparticle aggregation and dissociation, maintaining imaging accuracy while allowing for relatively simple synthesis through standard polymer encapsulation techniques
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution provides stable and effective X-ray contrast agents that can accurately image vasculature without causing vascular damage, offering improved radiopacity and safety by using nanoparticles that remain dispersed and functional within the vasculature, enhancing diagnostic accuracy.
Implementation Method 1
dispersed in alginate gels
Implementation Method 2
X-ray imaging is a very important technique to distinguish the vascular network from tissues with similar or low X-ray attenuation
Data Source
AI summary
Disclosed are capped abellaite (NaPb2(CO3)2OH), hydrocerussite (2PbCO3—Pb(OH)2), lead (II) carbonate (PbCO3), lead (II) tungstate (PbWO4), bismuth oxide (Bi2O3), and combinations thereof nanoparticles that are dispersed within an aqueous gelling solution to produce stable gels and function as an injectable contrast agent for vascular imaging. The contrast agent has good radioopacity, is inexpensive to produce, and is safe to handle. This provides a new method to image the fine vasculature of biological systems.